Skip Navigation


Glycobiology Advance Access originally published online on July 30, 2009
Glycobiology 2009 19(10):1103-1115; doi:10.1093/glycob/cwp101
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow Supplementary Data
Right arrow All Versions of this Article:
19/10/1103    most recent
cwp101v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Gandhi, N. S
Right arrow Articles by Mancera, R. L
PubMed
Right arrow PubMed Citation
Right arrow Articles by Gandhi, N. S
Right arrow Articles by Mancera, R. L
Social Bookmarking
 Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press. All rights reserved. For permissions, please e-mail: journals.permissions@oxfordjournals.org

Free energy calculations of glycosaminoglycan–protein interactions

Neha S Gandhi2,3,4 and Ricardo L Mancera1,2,3,4,5

2 Curtin Health Innovation Research Institute
3 Western Australian Biomedical Research Institute
4 School of Biomedical Sciences
5 School of Pharmacy, Curtin University of Technology, GPO Box U1985, Perth WA 6945, Australia


1 To whom correspondence should be addressed: Tel: +61-8-9266-1017; Fax: +61-8-9266-2769; e-mail: R.Mancera{at}curtin.edu.au

Received on May 12, 2009; revised on June 30, 2009; accepted on July 1, 2009

Glycosaminoglycans (GAGs) are complex highly charged linear polysaccharides that have a variety of roles in biological processes. We report the first use of molecular dynamics (MD) free energy calculations using the MM/PBSA method to investigate the binding of GAGs to protein molecules, namely the platelet endothelial cell adhesion molecule 1 (PECAM-1) and annexin A2. Calculations of the free energy of the binding of heparin fragments of different sizes reveal the existence of a region of low GAG-binding affinity in domains 5–6 of PECAM-1 and a region of high affinity in domains 2–3, consistent with experimental data and ligand–protein docking studies. A conformational hinge movement between domains 2 and 3 was observed, which allows the binding of heparin fragments of increasing size (pentasaccharides to octasaccharides) with an increasingly higher binding affinity. Similar simulations of the binding of a heparin fragment to annexin A2 reveal the optimization of electrostatic and hydrogen bonding interactions with the protein and protein-bound calcium ions. In general, these free energy calculations reveal that the binding of heparin to protein surfaces is dominated by strong electrostatic interactions for longer fragments, with equally important contributions from van der Waals interactions and vibrational entropy changes, against a large unfavorable desolvation penalty due to the high charge density of these molecules.

Key words: Annexin / PECAM-1 / GLYCAM / AMBER / heparin


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.